Sotera Health Company (SHC)

USD 13.2

(0.92%)

EBITDA Summary of Sotera Health Company

  • Sotera Health Company's latest annual EBITDA in 2023 was 514.14 Million USD , up 62.66% from previous year.
  • Sotera Health Company's latest quarterly EBITDA in 2024 Q2 was 125.67 Million USD , down -8.06% from previous quarter.
  • Sotera Health Company reported an annual EBITDA of -2.99 Million USD in 2022, down -5.36% from previous year.
  • Sotera Health Company reported an annual EBITDA of 404.24 Million USD in 2021, up 22.32% from previous year.
  • Sotera Health Company reported a quarterly EBITDA of 80.5 Million USD for 2024 Q3, up 40.48% from previous quarter.
  • Sotera Health Company reported a quarterly EBITDA of 100.63 Million USD for 2024 Q1, up 61.3% from previous quarter.

Annual EBITDA Chart of Sotera Health Company (2023 - 2018)

Historical Annual EBITDA of Sotera Health Company (2023 - 2018)

Year EBITDA EBITDA Growth
2023 514.14 Million USD 62.66%
2022 -2.99 Million USD -5.36%
2021 404.24 Million USD 22.32%
2020 319.96 Million USD -20.07%
2019 305.24 Million USD 8.45%
2018 316.59 Million USD 0.0%

Peer EBITDA Comparison of Sotera Health Company

Name EBITDA EBITDA Difference
Bionano Genomics, Inc. -213.6 Million USD 340.699%
Prenetics Global Limited -47.89 Million USD 1173.453%
Star Equity Holdings, Inc. -1.68 Million USD 30576.704%
CareDx, Inc -89.65 Million USD 673.454%
Exact Sciences Corporation 41.87 Million USD -1127.772%
Exagen Inc. -19.15 Million USD 2784.394%
Inotiv, Inc. -26.5 Million USD 2039.719%
Guardant Health, Inc. -433.3 Million USD 218.656%
Biodesix, Inc. -37.1 Million USD 1485.715%
BioNexus Gene Lab Corp. -2.48 Million USD 20788.479%
Precipio, Inc. -4.31 Million USD 12006.948%
iSpecimen Inc. -9.1 Million USD 5747.603%
Natera, Inc. -383.27 Million USD 234.144%
Aspira Women's Health Inc. -16.49 Million USD 3217.713%
Standard BioTools Inc. -54.45 Million USD 1044.125%
23andMe Holding Co. -291.87 Million USD 276.152%
Castle Biosciences, Inc. -45.02 Million USD 1241.929%
Personalis, Inc. -96.8 Million USD 631.1%
Aclaris Therapeutics, Inc. -117.56 Million USD 537.326%
Applied DNA Sciences, Inc. -9.59 Million USD 5460.649%
OpGen, Inc. -29.51 Million USD 1842.205%
T2 Biosystems, Inc. -43.87 Million USD 1271.834%
Myriad Genetics, Inc. -67.8 Million USD 858.322%
ICON Public Limited Company 1.63 Billion USD 68.49%
NeoGenomics, Inc. -17.6 Million USD 3020.1%
Star Equity Holdings, Inc. -1.68 Million USD 30576.704%
IDEXX Laboratories, Inc. 1.21 Billion USD 57.776%
RadNet, Inc. 292.78 Million USD -75.603%
MDxHealth SA -30.46 Million USD 1787.482%
Psychemedics Corporation -251 Thousand USD 204937.45%
Illumina, Inc. -608 Million USD 184.563%
Check-Cap Ltd. -17.64 Million USD 3013.151%
Twist Bioscience Corporation -176.7 Million USD 390.961%
DarioHealth Corp. -53.49 Million USD 1061.121%
Fulgent Genetics, Inc. -46.55 Million USD 1204.447%
Sera Prognostics, Inc. -35.28 Million USD 1557.03%
ENDRA Life Sciences Inc. -9.78 Million USD 5354.495%
OPKO Health, Inc. -65.51 Million USD 884.758%
Medpace Holdings, Inc. 363.15 Million USD -41.577%
Neogen Corporation 182.59 Million USD -181.572%
Intelligent Bio Solutions Inc. -8.81 Million USD 5935.423%
Prenetics Global Limited -47.89 Million USD 1173.453%
Mainz Biomed B.V. -25.01 Million USD 2155.647%
bioAffinity Technologies, Inc. -7.62 Million USD 6839.041%
Trinity Biotech plc -24.09 Million USD 2233.546%
Neuronetics, Inc. -22.75 Million USD 2359.071%
bioAffinity Technologies, Inc. -7.62 Million USD 6839.041%